Search Results

There are 35958 results for: content related to: AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia

  1. Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group

    Pediatric Blood & Cancer

    Volume 62, Issue 10, October 2015, Pages: 1775–1781, Kelly D. Getz, Yimei Li, Todd A. Alonzo, Matthew Hall, Robert B. Gerbing, Lillian Sung, Yuan-Shung Huang, Staci Arnold, Alix E. Seif, Tamara P. Miller, Rochelle Bagatell, Brian T. Fisher, Peter C. Adamson, Alan Gamis, Ron Keren and Richard Aplenc

    Version of Record online : 6 MAY 2015, DOI: 10.1002/pbc.25569

  2. Children's Oncology Group's 2013 blueprint for research: Acute myeloid leukemia

    Pediatric Blood & Cancer

    Volume 60, Issue 6, June 2013, Pages: 964–971, Alan S. Gamis, Todd A. Alonzo, John P. Perentesis, Soheil Meshinchi and on behalf of the COG Acute Myeloid Leukemia Committee

    Version of Record online : 19 DEC 2012, DOI: 10.1002/pbc.24432

  3. Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy

    British Journal of Haematology

    Volume 168, Issue 1, January 2015, Pages: 94–101, Seth E. Karol, Elaine Coustan-Smith, Xueyuan Cao, Sheila A. Shurtleff, Susana C. Raimondi, John K. Choi, Raul C. Ribeiro, Gary V Dahl, William Paul Bowman, Jeffrey W. Taub, Barbara Degar, Wing Leung, James R. Downing, Ching-Hon Pui, Jeffrey E. Rubnitz, Dario Campana and Hiroto Inaba

    Version of Record online : 28 AUG 2014, DOI: 10.1111/bjh.13107

  4. Calicheamicin Conjugates: Gemtuzumab Ozogamicin (Mylotarg), Inotuzumab Ozogamicin

    Handbook of Therapeutic Antibodies

    Matthias Peipp, Martin Gramatzki, Pages: 1545–1564, 2014

    Published Online : 12 AUG 2014, DOI: 10.1002/9783527682423.ch55

  5. You have free access to this content
    Gemtuzumab ozogamicin can reduce minimal residual disease in patients with childhood acute myeloid leukemia

    Cancer

    Volume 119, Issue 22, 15 November 2013, Pages: 4036–4043, Carol O'Hear, Hiroto Inaba, Stanley Pounds, Lei Shi, Gary Dahl, W. Paul Bowman, Jeffrey W. Taub, Ching-Hon Pui, Raul C. Ribeiro, Elaine Coustan-Smith, Dario Campana and Jeffrey E. Rubnitz

    Version of Record online : 4 SEP 2013, DOI: 10.1002/cncr.28334

  6. Association between prolonged neutropenia and reduced relapse risk in pediatric AML: A report from the children's oncology group

    International Journal of Cancer

    Lillian Sung, Richard Aplenc, Todd A. Alonzo, Robert B. Gerbing, Yi-Cheng Wang, Soheil Meshinchi and Alan S. Gamis

    Version of Record online : 4 JUL 2016, DOI: 10.1002/ijc.30236

  7. Gemtuzumab Ozogamicin (Mylotarg)

    Handbook of Therapeutic Antibodies

    Matthias Peipp, Martin Gramatzki, Pages: 869–883, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch33

  8. You have free access to this content
    Successful treatment with low-dose gemtuzumab ozogamicin in combination chemotherapy followed by stem cell transplantation for children with refractory acute myeloid leukaemia

    British Journal of Haematology

    Volume 158, Issue 5, September 2012, Pages: 666–668, Nao Yoshida, Hirotoshi Sakaguchi, Kimikazu Matsumoto and Koji Kato

    Version of Record online : 19 JUN 2012, DOI: 10.1111/j.1365-2141.2012.09192.x

  9. You have free access to this content
    The role of gemtuzumab ozogamicin in acute leukaemia therapy

    British Journal of Haematology

    Volume 132, Issue 4, February 2006, Pages: 398–409, Apostolia-Maria Tsimberidou, Francis J. Giles, Elihu Estey, Susan O'Brien, Michael J. Keating and Hagop M. Kantarjian

    Version of Record online : 24 NOV 2005, DOI: 10.1111/j.1365-2141.2005.05872.x

  10. You have free access to this content
    Preventive antibiotics in pediatric patients with acute myeloid leukemia (AML)

    Pediatric Blood & Cancer

    Volume 62, Issue 7, July 2015, Pages: 1149–1154, Dawn Nolt, Susan Lindemulder, Jeffrey Meyrowitz, Bill H. Chang, Suman Malempati, Gregory Thomas and Linda Stork

    Version of Record online : 1 MAR 2015, DOI: 10.1002/pbc.25463

  11. Pharmacokinetics of Gemtuzumab Ozogamicin as a Single-Agent Treatment of Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia

    The Journal of Clinical Pharmacology

    Volume 44, Issue 8, August 2004, Pages: 873–880, Mary Buckwalter, James A. Dowell, Joan Korth-Bradley, Boris Gorovits and Philip R. Mayer

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004267595

  12. Pharmacokinetics of Gemtuzumab Ozogamicin, an Antibody-Targeted Chemotherapy Agent for the Treatment of Patients with Acute Myeloid Leukemia in First Relapse

    The Journal of Clinical Pharmacology

    Volume 41, Issue 11, November 2001, Pages: 1206–1214, Dr. James A. Dowell, Dr. Joan Korth-Bradley, Dr. Hanjiu Liu, Dr. S. Peter King and Dr. Mark S. Berger

    Version of Record online : 8 MAR 2013, DOI: 10.1177/00912700122012751

  13. Impact of Age and Gender on the Pharmacokinetics of Gemtuzumab Ozogamicin

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 21, Issue 10, October 2001, Pages: 1175–1180, Joan M. Korth-Bradley, James A. Dowell, S. Peter King, H. Liu, Mark S. Berger and Mylotarg Study Group

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.21.15.1175.33890

  14. You have free access to this content
    Significance of expression of ITGA5 and its splice variants in acute myeloid leukemia: A report from the children's oncology group

    American Journal of Hematology

    Volume 88, Issue 8, August 2013, Pages: 694–702, Roland B. Walter, George S. Laszlo, Todd A. Alonzo, Robert B. Gerbing, Shawn Levy, Matthew P. Fitzgibbon, Chelsea J. Gudgeon, Rhonda E. Ries, Kimberly H. Harrington, Susana C. Raimondi, Betsy A. Hirsch, Alan S. Gamis, Martin W. McIntosh and Soheil Meshinchi

    Version of Record online : 20 JUN 2013, DOI: 10.1002/ajh.23486

  15. Acute Myeloid Leukemia

    Pediatric Hematology, Third Edition

    Leslie S. Kean, Robert J. Arceci, William G. Woods, Pages: 360–383, 2007

    Published Online : 4 OCT 2007, DOI: 10.1002/9780470987001.ch16

  16. You have free access to this content
    Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes

    Cancer

    Volume 97, Issue 6, 15 March 2003, Pages: 1481–1487, Apostolia Tsimberidou, Elihu Estey, Jorge Cortes, Deborah Thomas, Stefan Faderl, Srdan Verstovsek, Guillermo Garcia-Manero, Michael Keating, Maher Albitar, Susan O'Brien, Hagop Kantarjian and Francis Giles

    Version of Record online : 3 MAR 2003, DOI: 10.1002/cncr.11239

  17. You have free access to this content
    Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia

    Cancer

    Volume 98, Issue 10, 15 November 2003, Pages: 2095–2104, Francis Giles, Elihu Estey and Susan O'Brien

    Version of Record online : 7 OCT 2003, DOI: 10.1002/cncr.11791

  18. You have free access to this content
    Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients

    British Journal of Haematology

    Volume 138, Issue 2, July 2007, Pages: 186–195, Marino Clavio, Luana Vignolo, Alessandra Albarello, Riccardo Varaldo, Ivana Pierri, Gioacchino Catania, Manuela Balocco, Gianluca Michelis, Maurizio Miglino, Annunziata Manna, Enrico Balleari, A. Michele Carella, Mario Sessarego, Maria Teresa Van Lint, Andrea Bacigalupo and Marco Gobbi

    Version of Record online : 22 JUN 2007, DOI: 10.1111/j.1365-2141.2007.06646.x

  19. You have full text access to this OnlineOpen article
    A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropenia

    Cancer Medicine

    Volume 4, Issue 9, September 2015, Pages: 1356–1364, Kelly D. Getz, Tamara P. Miller, Alix E. Seif, Yimei Li, Yuan-Shung Huang, Rochelle Bagatell, Brian T. Fisher and Richard Aplenc

    Version of Record online : 24 JUN 2015, DOI: 10.1002/cam4.481

  20. You have free access to this content
    Possible association between Budd-Chiari syndrome and gemtuzumab ozogamicin treatment in a patient with refractory acute myelogenous leukemia

    American Journal of Hematology

    Volume 80, Issue 3, November 2005, Pages: 213–215, Mevlüt Kurt, Ali Shorbagi, Kadri Altundag, Tamer Elkiran, Ibrahim Güllü and Emin Kansu

    Version of Record online : 24 OCT 2005, DOI: 10.1002/ajh.20432